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1. Introduction 
The aim of this chapter is to describe several studies which have attempted to 
measure/detect effects of antioxidant compounds (lipoic acid, ubiquinone, ascorbic acid and 
alpha-tocopherol) on behavioral alterations, neuronal damage and oxidative stress in 
hippocampus of rodents in epilepsy model induced by pilocarpine. 
Epilepsy can cause an uncomfortable impact on social, educational and emotional 
development of affected people, especially in childhood and adolescence, but its diagnosis 
has had great progress over the last years. Nevertheless, among the diagnostic details 
requiring research, the precise localization and lateralization of epileptogenic focus remains 
unclear, despite the fact that it has been demonstrated that removal of cerebral cortex region 
may result in a state free of seizures. Moreover, epilepsy is considered a risk factor for 
depression and other psychological problems, whereas cognitive impairment may be related 
to behavioral troubles, particularly of conduct and attention deficit, hyperactivity and 
psychiatric disorders.  
Neurotransmitter systems involved in the experimental model of epilepsy induced by 
pilocarpine are not fully defined yet. This seizure model in rodents is widely used to study 
the pathophysiology of convulsive process, since it reproduces behavioral, 
electroencephalographic (EEG) and neurochemical changes that are similar to those of the 
temporal lobe epilepsy in humans. The pilocarpine model is used to study the action 
mechanism of new drugs and antioxidant compounds during the installation and 
maintenance and/or propagation of epileptogenesis as well as to evaluate effects of new 
compounds isolated from medicinal plants on behavioral, histopathological, and other 
parameters relating neurochemical changes with epileptic activity (Costa Júnior et al, 2010).  
Histopathological studies using this model have demonstrated neuronal damage in various 
brain regions. Some specific brain areas revealed typical histopathological changes, mainly 
hippocampus, striatum and frontal cortex, suggesting the involvement of these different 
areas during the establishment of the epileptic process. Among those areas, the cellular and 
structural modifications seen in hippocampus and striatum may be significantly related  to 
the mechanisms of installation and propagation in epileptogenesis of limbic seizures. 
The temporal lobe epilepsy is the most common form of epilepsy. It is characterized by 
spontaneous recurrent seizures that are often blocked by treatment with antiepileptic drugs. 
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Seizures can be characterized as clinical manifestations resulting from abnormal neuronal 
discharges, producing an imbalance between the mechanisms of inhibitory and excitatory 
neurotransmission. The mechanisms of activation, propagation and maintenance of seizures 
are widely studied but little understood. Many studies have been performed using the 
pilocarpine model to clarify the effects of new drug modulators on brain mechanisms of 
seizures and status epilepticus (Santos et al, 2010). 
Status epilepticus is clinically defined as prolonged electrical and clinical seizure activity in 
which the patient does not regain consciousness to a normal alert state between repeated 
tonic-clonic attacks. The disorder is a neurological emergency associated with a mortality 
rate of 10-12% and an even greater morbidity. Status epilepticus can lead to permanent 
pathological damage and altered physiological function in certain brain regions and induces 
major changes in membrane phospholipids, massive increases in arachidonic acid 
concentrations, diacylglycerol-mediated activation of protein kinase C, calcium-mediated 
changes in calmodulin kinase II and possibly generation of free radicals that could play an 
essential role in mechanism of oxidative stress involved in neuronal damage. Status 
epilepticus can be characterized by a permanent change in neurotransmitter systems and 
oxidative stress that it is more facilitated in the brain rather than in other tissues because it 
contains large quantities of oxidizable lipids and metals (Freitas et al, 2010). Moreover, 
status epilepticus can produce considerable changes on the enzymatic activity of 
antioxidants systems according to the brain areas and the phase of the seizure studied.  
The role of monoamines, amino acid and oxidative stress in pilocarpine model was 
investigated in hippocampus, striatum and frontal cortex of adult rats. The status 
epilepticus was induced by pilocarpine and the results correspond to its acute phase. The 
data obtained suggest that pilocarpine induced neurotransmitters and oxidative stress 
changes in brain regions which are similar to those found in human temporal lobe epilepsy 
(El-Etri et al, 1993, Freitas et al, 2003, Ferreira et al, 2009).  
2. Pathophysiology of seizures in epilepsy model induced by pilocarpine  
Epilepsies are complex neurobehavioral disorders resulting from increased excitability of 
neurons in several brain regions involving various neurotransmitters (Rauca et al, 2004). The 
cholinergic system plays an important role in generating EEG activity as well as regulating 
the vigilance states. Pilocarpine is a cholinergic agonist with a moderate affinity with M1 
muscarinic receptors and high affinity with M5 ones. Muscarinic cholinergic agonists have 
effects on rapid eyes movement (REM) and slow wave sleep, playing a role in REM 
induction (MacGregor et al, 1997; Perlis et al, 2002). On the other hand, pilocarpine at a high 
dose (400 mg/kg, i.p.)  makes seizures progress to a long-lasting status epilepticus (SE) 
within 1-2 h and induces behavioral and EEG alterations in rodents, which are similar to 
human temporal lobe epilepsy (TLE) (Marinho et al, 1998).   
Pilocarpine-induced rodent models TLE might provide information regarding 
histopathological damage and oxidative stress consequences, as well as neurochemical 
changes associated with seizure activity in hippocampus of young and adult rats 
(Cavalheiro et al, 1991; Smith and Shibley, 2002, Freitas et al, 2003). TLE can be characterized 
by a permanent change in neurotransmitter systems and in development of the oxidative 
stress that is more facilitated in the brain rather than in other tissues because for several 
reasons, including a high consumption of oxygen, the presence of large quantities of 
oxidizable lipids and pro-oxidative metals, and its comparatively lower antioxidant capacity 
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(Frantseva et al, 2000; Naffah-Mazzacoratti et al, 2001). Neuronal cells continuously produce 
free radicals and reactive oxygen species (ROS) as part of their metabolic processes and 
during the establishment of convulsive process (Gilbert and Sawas, 1983; Halliwell and 
Gutteridge, 1999). The free radicals are very reactive and might produce oxidative damage 
in DNA, proteins and lipids (Peterson et al, 2002), leading to a sequence of outcomes that 
culminates in neuronal degeneration during the installation of seizures.  
ROS can affect the ion transport, proteins and channels, via protein oxidation or  
via membrane phospholipids peroxidation, resulting in a deleterious change on the ionic 
homeostasis and the neuronal transmission (Rong et al, 1999; Sah et al, 2002). The ROS 
increment induces oxidative stress, which is defined as the excessive production of free 
radicals, such as superoxide (O2-), hydroxyl radical (OH.), nitric oxide (NO) and their 
metabolites (nitrate and nitrite) and others that can dramatically alter the neuronal function. 
Therefore, some researches have correlated the overproduction of these compounds  
with seizure-induced neuronal death and status epilepticus (MacGregor et al, 1997; Ferrer et 
al, 2000).  
Several compounds can produce free radical such as H2O2, which in high concentration can 
react with O2- (Haber-Weiss reaction) or iron (Fenton reaction) producing highly reactive 
OH. The conversion of H2O2 to H2O and O2 is made by catalase and glutathione peroxidase 
(Michiels et al, 1994; Simonié et al, 2000). The formed OH. radical is likely to react with non-
radical molecules, transforming them into secondary free radicals. This reaction occurs 
during the lipid peroxidation producing hydroperoxides in brain epileptic (Vanhatalo and 
Riikonen, 1999). Nitric oxide (NO) can be estimated by their metabolites, which are 
associated with neurodegenerative diseases (Vanhatalo and Riikonen, 2001). Despite the fact 
that numerous studies clearly indicate the importance of antioxidant enzymatic activities in 
the epileptic phenomenon, the mechanisms by which these enzymes influence seizures and 
status epilepticus are not completely understood (Michiels et al, 1994; Simonié et al, 2000). 
Status epilepticus is a severe form of continuous seizure attacks and a medical emergency 
associated with brain damage and significant mortality (Aminoff and Simon, 1980). The 
common sequels of status epilepticus include continuing recurrent seizures, permanent 
neurological deficit and brain injury. The status epilepticus can be induced by the 
administration of pilocarpine or lithium-pilocarpine (Hirsh et al, 1982; Freitas et al, 2004). 
Pilocarpine administration induces seizures with three distinct phases: [A] an acute period, 
which lasts 1-2 days and is associated to repetitive seizures and status epilepticus; [B] a 
seizure-free (silent period) characterized by a progressive return to normal EEG and 
behavior, which lasts 4 to 44 days; [C] a chronic period characterized by spontaneous 
recurrent seizures (SRS) that starts 5 to 45 days after pilocarpine administration and persists 
until the animal dies. In addition, systemic injection of pilocarpine induces status epilepticus 
in rodents associated to histopathological alterations, which are most prominent in limbic 
structures (Cavalheiro et al, 1991), such as hippocampus, striatum, frontal cortex and others 
(Tomé et al, 2010). 
Pilocarpine is a muscarinic cholinergic agonist able to elicit seizures and status epilepticus in 
rodents, characterizing an experimental model frequently used to study SRS (Turski et al, 
1983; Freitas et al, 2005). This seizure model resembles several phenomenological features of 
human temporal lobe epilepsy, including a particular resistance to anticonvulsant 
medication (Browne and Holmes, 2001). Tissue accumulation of free radicals can occur in 
many metabolic disorders, such as seizures. Affected patients present a variable degree of 
neurological dysfunction, including mental retardation, cognitive deficit and cerebral 
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edema. However, the exact mechanisms involved in these alterations remain poorly 
understood. 
It has been described that the impairments in learning, memory and behavior observed in 
patients with epilepsy are caused, at least in part, by changes in cholinergic system function 
(Bruce and Baudry, 1995), since there are consistent evidence that high levels of 
acetylcholine (ACh) in the brain are associated with cognitive dysfunction (Brozek et al, 
2000). Cholinergic transmission is mainly terminated after ACh hydrolysis cause by 
acetylcholinesterase enzyme (AChE).  
In the brain, the phenomena of excitotoxicity has been related to an over production of free 
radicals by the tissue during pilocarpine-induced seizures and status epilepticus (Simonié et 
al, 2000) and in human epilepsy (Vanhatalo and Riikonen, 1999). The increase in ROS levels 
can be responsible for this neuropathology and can activate apoptosis processes (Rong et al, 
1999). The free radicals in the convulsive process can be neutralized by an elaborate 
antioxidant defense system consisting of enzymes such as superoxide dismutase, 
glutathione peroxidase, catalase, and glutathione reductase, and numerous non-enzymatic 
antioxidants like reduced glutathione (GSH), indicating a neuronal response (Ferrer et al, 
2000). Status epilepticus induces ROS production by protein oxidation measured by tyrosine 
nitration (Rong et al, 1999). It can also be determined by both the end-product of lipid 
peroxidation, malondialdehyde (MDA) levels (Bruce and Baudry, 1995), and the 
effectiveness of the antioxidant enzymatic responses (Dal-Pizzol et al, 2000). The 
hippocampus is the most affected area by pilocarpine-induced seizures. Other authors also 
characterized the neuropathology associated with this convulsive process in striatum, 
frontal cortex, thalamus and amygdala (Perlis et al, 2002; Freitas et al, 2004).  
Seizures represent one of the most severe in vivo stimulatory stress that the brain is exposed 
to and generalized status epilepticus represents a very severe form of seizures. The 
international Classification of seizures has defined it as a condition characterized by an 
epileptic seizure that is so frequent or so prolonged as to create a fixed and lasting condition 
(Krug et al, 1981). Major motor status epilepticus can lead to permanent pathological 
damage and altered physiological function in certain brain regions. The pathophysiological 
changes seen in complex partial, simple partial and absence status epilepticus are much less 
clear (Freitas et al, 2005). SE can cause brain damage, but can also result from it, and it has 
been difficult to separate the two, particularly in humans (Lapin et al, 1998). 
Status epilepticus has been widely studied in animal models. In status epilepticus, 
glutamate, aspartate, serotonin, dopamine and acetylcholine play major roles as excitatory 
neurotransmitters, and GABA as the dominant inhibitory neurotransmitter (Hort et al, 2000; 
Costa-Lotufo et al, 2002). However, the relation among brain excitatory and inhibitory 
neurotransmitters and status epilepticus cannot be perfectly established yet and deserves 
further studies with the purpose to clarify the pathophysiology of seizures.  
The pathophysiology of epilepsy is not yet fully defined. The pilocarpine model of seizures 
in animals are widely used to study the pathophysiology of convulsive process (Ben-Ari et 
al, 1980), since it reproduces the behavioral and EEG changes that are similar to humans 
TLE (Ben-Ari et al, 1981). These models are used to study the involvement of 
neurotransmitter systems as modulators of epileptogenesis, but also to observe behavioral 
changes, histopathologic, and other neurochemical parameters related to seizure activity 
(Marinho et al, 1997; Costa- Lotufo et al, 2002, Freitas et al, 2006). 
In general, pilocarpine-induced seizures seem to depend on activation of muscarinic 
receptor, the enzymatic activity changes in some systems (Simonié et al, 2000; Naffah-
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Mazzacoratti et al, 2001; Liu et al, 2002), metabolism of fosfoinositídios (Marinho et al, 1998), 
as well as on the involvement of other neurotransmitter systems such as noradrenergic, 
dopamine (Kulkarni and George, 1996), serotonergic, GABAergic (Loup et al. 1999; Costa-
Lotufo et al, 2002) and glutamatergic (Massieu et al. 1994; Chamberlain et al, 2000). 
3. Behavioral alterations in epilepsy model  
Status epilepticus is an emergency situation which requires prompt medical atentem. If it is 
severe permanent brain damage or death has to be prevented with pretreatment with 
antioxidant compounds. Status epilepticus often occurs in individuals with a history of 
seizures, in whom there are neuronal substrates already predisposed towards supporting 
seizure activity. 
The pilocarpine model is an useful animal experimental to investigate the development of 
acute, silent and chronic phases (Cavalheiro et al, 1991). Immediately after pilocarpine 
administration, all animals persistently presented behavioral changes, including initial 
akinesia, ataxic lurching, peripheral cholinergic signs (miosis, piloerection, 
chromodacryorrhea, diarrhea and masticatory automatisms), stereotyped movements 
(continuous sniffing, paw licking, rearing and wet dog shakes that persisted for 10-15 min), 
clonic movements of forelimbs, head bobbing and tremors. 
These behavioral changes progressed to motor limbic seizures as previously described  
by Tursky et al. (1983a). Limbic seizures lasted for 30-50 min evolving to status epilepticus 
for a period longer than 30 min. During 1 h of acute phase of seizures, no case of fatality was 
observed between the adult rats. However, during the 24 h observation of this phase, 63%  
of adult animals died (Cavalheiro et al, 1994; Todorova et al, 2004). Similarly, these results 
for the behavioral alterations in pilocarpine model were described previously by Marinho et 
al. (1998).  
According to our previous studies (Freitas et al, 2004), few minutes after pilocarpine 
administration, the animals exhibited stereotyped oral and masticatory movements, 
hypokinesia, salivation, tremor and partial or generalized limbic seizures. Approximately 30 
min after pilocarpine injection, the seizures evolved to status epilepticus lasting 12-18 h. 
During this period, 40% of animals died due to SE. This acute phase was followed by a silent 
period varying from 4 to 44 days (mean of 15 days) during which the animals displayed 
normal behavior. A chronic period of spontaneous and recurrent seizures (SRS) (3-4 
seizures/week) was also observed and all animals which survived SE, displayed the chronic 
phase. During the interictal period, there were no behavioral alterations in the animals. 
In epilepsy model, pilocarpine induced the first seizure to occur at 34.93 ± 0.70 min. All the 
animals that received pilocarpine injection (at a dose 400 mg/kg, i.p.) presented generalized 
tonic-clonic convulsions with status epilepticus, and 60% survived the seizures (Freitas et al, 
2004).  
4. Antioxidant compounds effects on behavioral alterations in epilepsy model 
The nervous system contains some antioxidant enzymes, including superoxide dismutase 
and glutathione peroxidase that are expressed in higher quantities than catalase 
(Shivakumar et al, 1991). This spectrum of enzymatic defense suggests that the brain may 
efficiently metabolize superoxide, but it may have difficulties in eliminating the hydrogen 
peroxide produced by this reaction. The accumulation of hydrogen peroxide is of major 
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concern since the brain contains large quantity of iron and copper, which may catalyze the 
formation of hydroxil radical, which, in turn, can induce lipid peroxidation (Castagne et al, 
1999). 
The glutathione peroxidase is presented in large amounts during the Central Nervous 
System (CNS) development, but decreases in aged rats (Nanda et al, 1996). Nevertheless, 
other scavengers such as ascorbic acid and alpha-tocopherol also decrease the propagation 
of radical chain reaction. For these reasons, free radicals have been pointed as important 
molecules involved in the nervous system pathologies such as Huntington disease, 
Alzheimer, ischaemia and epilepsy (Jenner, 1998). 
In epilepsy model induced by pilocarpine administration, we found that superoxide 
dismutase and catalase activities in the hippocampus are not altered during the acute phase 
of seizures. On the other hand, according to several authors, the augment of these enzymatic 
activities could decrease the O2- and H2O2 levels. Taken together, these results show that 
during the acute phase, the hippocampus of the adult animals in pilocarpine model after 
seizures is more vulnerable to oxidative stress. 
In addition, high-levels of hydroperoxides were also observed in the same group of animals, 
which indicated that the lipid peroxidation could be dependent of disability of the 
antioxidant enzymatic (superoxide dismutase and catalase) activities. As the 
hydroperoxides are a class of compounds produced as the result of phospholipid 
peroxidation, its high concentration in the tissue suggests that the hippocampal cells are 
more vulnerable to damage during the acute period of seizures. Thus, the results described 
in literature about pilocarpine model suggest that the beneficial effects of antioxidants 
compounds in reducing the behavioral changes caused by seizures may be partly explained 
by their ability to remove free radicals, and prevent the formation of hydroperoxides in 
hippocampus of seized rats. 
The need for animal models of epilepsy is driven by the constraints of studying human 
epileptic brain. Although a great deal has been learned through the study of human 
epileptic brain tissue throughout the past 100 years, and particularly based in recent 
experiments  with pilocarpine model, our work was aimed at investigating the antioxidant 
effects of lipoic acid, ubiquinone, ascorbic acid and alpha-tocopherol in adult rats under 
pilocarpine-induced seizures. Our studies have demonstrated that all animals pretreated 
with the lipoic acid at the dose (10 or 20 mg/kg) during the first hour of acute phase of 
seizures induced by pilocarpine injection also manifested behavior alterations, such as 
peripheral cholinergic signs, tremors, staring spells, facial automatisms, wet dog shakes, 
rearing and motor seizures, which develop progressively within 1-2 h into a long-lasting 
status epilepticus. However, these behavioral changes occur at lower rates (Table 1). The 
findings also suggest that when administered 30 min before pilocarpine, lipoic acid reduces 
the percentage of animals that seized, increases latency to the first seizure and the survival 
percentage (Table 1). 
Corroborating these data, other antioxidant compound evaluated in pilocarpine model 
when administered at the dose of 5 mg/kg before pilocarpine, ubiquinone had no effects on 
seized animals and survival percentage, but increased latency to the first seizure, when 
compared with the pilocarpine group (Table 1). On the other hand, at a dose of 10 or 20 
mg/kg ubiquinone produced a higher reduction of seizures percentage, and a higher 
increase to that produced by dose of 5 mg/kg in latency to the first seizure and survival rate 
in pilocarpine model (Table 1). 
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Drugs 
Dose 
(mg/kg) 
Cholinergic 
Reactions (%) 
Latency to first 
seizure (min) 
Seizures 
(%) 
Status 
epilepticus (%) 
Survival 
rate 
(%) 
Pilocarpine 400 100 35.00 ± 0.70 75 75 40 
Ascorbic acid 250 100 80.00 ± 1.30* 33a 33a 100a 
 500 100 189.19 ± 1.15*,** 25a,b 25a,b 100a,b 
Alpha-
tocopherol 
200 100 103.00 ± 0.90* 32a 32a 68a 
 400 100 158.10 ± 1.05*,** 16a,b 16a,b 70a,b 
Ubiquinone 5 100 69.00 ± 0.65* 60a 60a 60a 
 10 100 89.00 ± 0.83*,** 35a,b 35a,b 75a,b 
Lipoic acid 10 100 106.13 ± 1.05* 00a 00a 75a 
 20 100 119.00 ± 1.02* 10a 10a 90a 
Rats were acutely treated with the drug doses shown in the table above and 30 min afterwards they 
received pilocarpine (400 mg/kg). Following, the animals were observed for 24 h for assessment of 
cholinergic reactions, motor seizures which develop progressively within 1-2 h into a long-lasting status 
epilepticus and survival rate. Results of latency to first seizure and latency to installation of status 
epilepticus are expressed in minutes (min) as mean ± S.E.M of the number of experiments shown in the 
experimental groups and the others in percentages  *p<0.05, vs pilocarpine. **p<0.05 vs lower dose 
(ANOVA and t-Student Newman Keuls post hoc test);  ap<0.05, vs pilocapine. bp<0.05, vs lower dose  
(χ2 test). 
Table 1. Effect of pretreatment with antioxidant drugs on behavioral alterations in 
pilocarpine-induced seizures and lethality in adult rats. 
In preclinical practice, the animals pretreated with ascorbic acid (250 mg/kg) in pilocarpine 
model developed cholinergic reactions, 33% had seizures, 25% built up to status epilepticus 
and no animal died (Table 1). Ascorbic acid administration, 30 min before pilocarpine 
injections, increased the latency to the onset of the first seizure in 129% and latency of the 
status epilepticus in 195% (Table 1). In pilocarpine model, it is also shown that when 
administered at the smaller dose (200 mg/kg), 30 min before pilocarpine injection, alpha-
tocopherol can be decrease by 43% the percentage of animals that seized, increased (194%) 
latency to the first seizure, and increased survival (41%) (Table 1). 
Conversely, a higher dose (500 mg/kg) of the ascorbic acid in pilocarpine model, produced 
changes in behavior with lower intensity, such as peripheral cholinergic signs (100%), 
staring spells, facial automatisms, wet dog shakes, rearing and motor seizures (25%) were 
observed, which progressively developed (1-2 h) into long-lasting status epilepticus (25%), 
revealing a survival rate of 75% (Table 1). Other studies have revealed that alpha-tocopherol 
at a dose 400 mg/kg blocks all alterations in behavior, revealing only 16% of motor seizures, 
which progressively developed (1-2 h) into long-lasting status epilepticus in pilocarpine 
model and a survival rate of 84% from the seizures (Table 1). 
5. Histopathological alterations in epilepsy model  
Cholinergic mechanisms play an important role in the activation of limbic seizures, and 
dopaminergic, serotonergic, GABAergic and glutamatergic systems are responsible for the 
propagation and/or maintenance of seizures and status epilepticus induced by pilocarpine 
(Freitas et al, 2004). Previous studies have described a model of limbic seizures followed by 
brain damage produced by systemic injection of a high dose of pilocarpine in rats. The 
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evidence included temporal correlation among free radical generation, development of 
seizures and neuroprotective effects of antioxidant drugs against neuronal damage caused 
by seizures (Kabuto et al, 1998).  
Other studies have shown pilocarpine-induced seizures and brain damage in various 
cerebral regions and a significant hippocampal injury in this epilepsy model (Turski et al, 
1991; Curia et al, 2008). The anticonvulsant effect in the absence of anticholinergic drugs 
subsequent to the seizure onset suggests that muscarinic receptor activation is involved 
directly in the beginning of seizures by pilocarpine.  
However, the oxidative stress might also play an essential role in the production of neuronal 
damage, which can be justified by neuroprotective actions of antioxidant compounds 
according to previous studies (Freitas et al, 2004; Xavier et al, 2007; Ayyildiz et al, 2007a). 
Previous research indicates that anticonvulsant effects of noradrenergic antagonist drugs have 
a fundamental role in the mechanisms responsible for beginning, severity and duration of 
seizure. In fact, the reduction of severity and duration of seizures are protective against 
neurotoxicity caused by seizures induced by chemical convulsants (e.g. pilocarpine, kainic acid 
and others). These data, in spite of confirming a pivotal role of anticonvulsant drugs in 
modulating seizure threshold and neuronal death, offer a novel target, which may be used to 
develop anticonvulsant and neuroprotective agents (Pizzanelli et al, 2009). 
There are several indications that free radical plays a role in epileptogenesis. During 
seizures, the ROS concentration and brain lipid peroxidation increase (Curia et al, 2008). It is 
currently hypothesized that any pathological process such as status epilepticus, which 
releases dopamine and glutamate, activates D2 and NMDA receptors.  
This may lead to neuronal necrosis by elevating intracellular calcium and activating 
potentially destructive calcium-dependent enzymes, augmenting the production of free 
radicals during seizures induced by pilocarpine (Michotte et al, 1997).  
The available experimental data suggest that convulsion generally accelerate brain damage. 
Limbic status epilepticus causes neuronal necrosis in hippocampus, amygdala, pyriform 
cortex, entorhinal cortex, thalamus, neocortex, striatum and substantia nigra (Ayyildiz et al, 
2007b). The neuronal damage depends on synaptic activation (Vanin et al, 2003), probably 
via a glutamatergic calcium-medited mechanism (Marinho et al, 1998).  
In the epilepsy model induced by a high dose of pilocarpine, we can observe neuronal loss 
in some brain areas, namely the hippocampus, striatum, amygdala, piriform cortex, 
entorhinal cortex, lateral septum, thalamus and substantia nigra, suggesting the 
involvement of these different areas during the establishment of the epileptic process 
(Honchar et al, 1983; Turski et al, 1983; Clifford et al, 1987; Marinho et al, 1997; Borelli et al, 
2002; Freitas et al, 2006). 
Among the areas in which neuronal damage occurs, the striatum and fronto-parietal cortex, 
besides being the most affected areas, may be related in important ways with the mechanism 
of propagation and/or maintenance (epileptogenesis) limbic seizures (Marinho et al, 1998). 
Barone and collaborators (1991) demonstrated that through intracerebral administration in the 
striatum of D2 dopamine agonists, there was a protection with respect to the development of 
seizures in adult rats, suggesting the participation of this brain region in limbic seizures. 
Histopathological examinations during the acute phase of seizures induced by pilocarpine 
show extensive hippocampal brain damage, pyriform, entorhinal, frontal, temporal and 
parietal cortices and in the  striatum and amygdaloid nucleus (Marinho et al, 1997). 
Cerebral lesions during the acute period are characterized by neuronal loss, gliosis and 
vacuolation, although there are contradictory data with respect to the severity and relative 
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distribution of brain damage (Mello et al, 1993). Brain necrosis is associated with the 
occurrence of seizures, although studies have demonstrated that this association is not 
obligatory, especially in the pilocarpine model (Peredery et al, 1992). The seizures induced 
by pilocarpine can be blocked by atropine, pointing towards involvement of the cholinergic 
system. On the other hand, atropine did not act after seizure onset, suggesting that others 
neurotransmitters and oxidative stress may participate in the maintenance and/or 
propagation of seizures and brain damage as well (Hirsh et al, 1982). Oxidative stress 
mediated by free radical produces lipid peroxidation, increases the nitrite content in the 
hippocampus, striatum and frontal cortex (Freitas et al, 2004) and may play a major role in 
the neuronal injury development after seizures induced by pilocarpine. 
6. Antioxidant compound effects on histopathological alterations in  
epilepsy model  
Hence, it could be expected that antioxidant drugs such as ascorbic acid and alpha-tocopherol, 
can be used as scavengers of free radicals, reducing brain injury induced by pilocarpine.  
In previous histopathological analyses, ascorbic acid and alpha-tocopherol antioxidants 
protected animals against seizures, status epilepticus and brain damage induced by 
pilocarpine (Figure 1) by decreasing the percentage of seizures, status epilepticus and death in 
relation to both doses tested.  
 
Fig. 1. Histopathological alterations in rat hippocampus treated with pilocarpine, ascorbic acid 
or their combinations. [A] Control group; [B] Pilocarpine group; [C] ascorbic acid 250 group; 
[D] ascorbic acid 250 plus Pilocarpine groups was treated with ascorbic acid (250 mg/kg) and 
30 min before Pilocarpine; [E] ascorbic acid 500 group; [F] ascorbic acid 500 plus Pilocarpine 
group was treated with ascorbic acid (500 mg/kg) and 30 min before Pilocarpine. Severity of 
lesion was expressed as mean ± S.E.M. of scores of damage based in a scale from zero (none) to 
100 (total) percent of structural involvement. Brain damage was considered positive if there 
was at least 50% hippocampal involvement. Hematoxylin & Eosin staining (H&E). 
Magnification, 100 X. One representative experiment with n=6 is shown. 
A B C D 
E F G H 
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A variety of epilepsy models reflect the effects of acid ascorbic and alpha-tocopherol and 
specify their action (Koza et al, 2007; Gaby, 2007). Previously, it had been demonstrated that 
these compounds reduced the frequency of penicillin-induced epileptiform activity 
(Ayyildiz et al, 2006; Ayyildiz et al, 2007b). In recent years, many roles of alpha-tocopherol 
have been discovered, including not only an antioxidant function, but also pro-oxidant, cell 
signaling, and gene regulatory functions. Some studies have reported that alpha-tocopherol 
is considered to be the main antioxidant substance in the human body, interfering with the 
production of hydroxyl radical and also with the oxygen in cell membranes, thereby 
reducing lipid peroxidation (Barros et al, 2007).  
Our results demonstrated that seizure pattern and brain damage observed in pilocarpine-
treated animals differ from those pretreated with alpha-tocopherol (400 mg/kg) plus 
pilocarpine (400 mg/kg). The latter reproduced the syndrome with lower intensity  
of histopathological changes and mortality rate, in comparison with the alpha-tocopherol 
(200 mg/kg) plus pilocarpine, corroborating the outcomes obtained by Ribeiro and 
collaborators (2005) and Ayyildiz and collaborators (2006). The percentage of status 
epilepticus (75%) that was found further corroborated prior investigations (Clifford et al, 
1987; Marinho et al, 1997). 
Ascorbic acid is probably the most important water-soluble antioxidant in the brain 
extracellular fluid, and it is essential in regenerating reduced alpha-tocopherol in 
membranes (Niki, 1991). Despite the fact that ascorbic acid has an antioxidant role to 
counter oxidative stress, ascorbic acid also form reactive oxidants, especially in the presence 
of transition metals. The evidence suggests that ascorbic acid participates in pro-oxidant 
reactions under certain conditions (Layton et al, 1998).  
The outcomes confirm that ascorbic acid (250 or 500 mg/kg) decreased the frequency of 
pilocarpine-induced seizures, status epilepticus and brain lesions in rats. In addition, 
ascorbic acid decreases the severity of hippocampal lesions and mortality rate caused by 
pilocarpine. Yamamoto and collaborators (2002) demonstrated that the injection of 
ascorbate, 60 min before FeCl3 administration, prevented the occurrence of epileptic 
discharges. Since there are wide variations of alpha-tocopherol and ascorbic acid doses used 
in different models of seizure, more detailed investigations are necessary before an ultimate 
conclusion on the effects of those compounds on pilocarpine-induced seizures can be 
achieved. 
In conclusion, there is an accumulation of free radicals after status epilepticus induced by 
pilocarpine, and oxidative changes in other parameters during the acute phase. This finding 
suggests that seizures, status epilepticus and deaths induced by pilocarpine have a large 
participation in brain oxidative stress, which is closely related to the mechanism of 
propagation and/or maintenance of the epileptic focus by pilocarpine. These results suggest 
that free radicals as well as the muscarinic receptor activation seem to be involved in the 
genesis of seizures and brain damage obtained with pilocarpine. On the other hand, the 
muscarinic activation seems to play a major role in the neuronal damage produced by 
pilocarpine. Antioxidant compounds can exert neuroprotective function during acute phase 
of seizures, thereby decreasing the severity of hippocampal lesions. All these outcomes 
indicate the promising therapeutic potential of ascorbic acid and alpha-tocopherol in 
treatments for neurodegenerative diseases. 
Brain tissue examinations of the animals pretreated with ascorbic acid (250 or 500 mg/Kg; 
Figure 1), alpha-tocopherol (200 or 400 mg/kg Figure 2), lipoic acid (10 or 20 mg/kg, Figure 
3) or ubiquinone (5 or 10 mg/kg; Figure 4), did not reveal hippocampal and striatal 
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histopathological changes. Then again, pilocarpine-treated animals presented neuronal loss, 
gliosis, and typical vacuolar degeneration in hippocampus and striatum regions. 
Histopathological damage in hippocampus was observed in 50, 33, 33 and 17% of the 
animals co-administered with ascorbic acid (250 or 500 mg/kg) or alpha-tocopherol (200 or 
400 mg/kg), and that 30 min after pretreatment received pilocarpine (400 mg/kg), 
respectively (Table 2). In addition, the analyses of histopathological damage in 
hippocampus of rats pretreated with lipoic acid (10 or 20 mg/kg) or ubiquinone (5 or 10 
mg/kg), and that 30 min after pretreatment received pilocarpine (400 mg/kg) revealed a 
reduction of 52, 68, 52 and 100% in the number of animals with neuronal damage, 
respectively (Table 2). 
 
Drugs 
Dose 
(mg/kg) 
Rats with lesion 
(%) 
Severity of lesion 
(%) 
Number of animals 
with lesion per 
group 
Pilocarpine 400 83 59.92 ± 0.23 5 
Ascorbic acid 250 00 00 0 
 500 00 00 0 
Ascorbic acid plus P400 250 50a 20.00 ± 0.32a 3 
 500 33a,b 17.66 ± 0.33a,b 2 
Alpha-tocopherol 200 00 00 0 
 400 00 00 0 
Alpha-tocopherol plus P400 200 33a 13.66 ± 0.33a 2 
 400 17 a,b 5.97 1 
Ubiquinone 5 00 00 0 
 10 00 00 0 
Ubiquinone plus P400 5 33a 12.00 ± 0.25a 2 
 10 00 00 0 
Lipoic acid 10 00 00 0 
 20 00 00 0 
Lipoic acid plus P400 10 33a 11.96 ± 0.12a 2 
 20 17 a,b 5.97 1 
Pilocarpine was administered in a single dose (400 mg/kg, P400, n=6), ascorbic acid groups with 
ascorbic acid (250 or 500 mg/kg), alpha-tocopherol (200 or 400 mg/kg, n=6), ubiquinone (5 or 10 
mg/kg, n=6) and lipoic acid group with lipoic acid (10 or 20 mg/kg; n=6). The ascorbic plus P400 
groups were treated with ascorbic acid (250 or 500 mg/kg, n=6) and 30 min before P400. The alpha-
tocopherol plus P400 group was treated with alpha-tocopherol (200 or 400 mg/kg) and 30 min before 
P400. The ubiquinone plus P400 group was treated with ubiquinone (5 or 10 mg/kg) and 30 min before 
P400. The lipoic acid plus P400 group was treated with lipoic acid (10 or 20 mg/kg) and 30 min before 
P400. Severity of lesion was expressed as mean ± S.E.M. of scores of damage based on a scale from zero 
(none) to 100 (total) percent of structural involvement. Brain damage was defined as present if there 
was at least 50% hippocampal involvement. Results for % rats with brain lesion and % severity of lesion 
are expressed as percentages of the number of animals inside in parenthesis. ap<0.05 compared with 
P400 group (χ2 test). bp<0.05 compared with ascorbic acid 250 plus P400 group or alpha-tocopherol 200 
mg/kg plus P400 group or ubiquinone 5 mg/kg plus P400 group or lipoic acid 10 mg/kg plus P400 
group (χ2 test). 
Table 2. Histopathological alterations in hippocampus of rats pretreated with antioxidant 
compounds after 24 h of phase acute of pilocarpine-induced seizures. 
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Histopathological damage in striatum was observed only in 33, 17, 17 and 17% of the 
animals co-administered with ascorbic acid (250 or 500 mg/kg), ubiquinone (5 mg/kg) and 
lipoic acid (10 mg/kg) and that 30 min after pretreatment received pilocarpine (400 mg/kg), 
respectively (Table 2). Moreover, the analyses of histopathological damage in striatum of 
rats pretreated with lipoic acid (20 mg/kg), alpha-tocopherol (200 or 400 mg/kg) or 
ubiquinone (10 mg/kg), and that 30 min after pretreatment received pilocarpine (400 
mg/kg) revealed no neuronal damage (Table 2). 
 
 
Fig. 2. Histopathological alterations in rat hippocampus treated with pilocarpine, atropine, 
alpha-tocopherol or their combinations. [A] Control group; [B] Pilocarpine group; [C] alpha-
tocopherol 200 group; [D] alpha-tocopherol 200 plus Pilocarpine group was treated with 
alpha-tocopherol (200 mg/kg) and 30 min before P400; [E] alpha-tocopherol 400 group; [F] 
alpha-tocopherol 400 plus Pilocarpine group was treated with alpha-tocopherol (400 
mg/kg) and 30 min before Pilocarpine. Severity of lesion was expressed as mean ± S.E.M. of 
scores of damage based in a scale from zero (none) to 100 (total) percent of structural 
involvement. Brain damage was considered positive if there was at least 50% hippocampal 
involvement. Hematoxylin & Eosin staining (H&E). Magnification, 100 X. One 
representative experiment with n=6 is shown. 
7. Oxidative stress in epilepsy model  
The lipid peroxidation level in the brain homogenates are increased in this model. During 
the acute phase of seizures induced by pilocarpine, increases in lipid peroxidation level, 
nitrite concentration and GSH content in striatum, frontal cortex and hippocampus have 
been verified in the same way (Freitas et al, 2004).  The improved review demonstrates that 
status epilepticus induces different changes in superoxide dismutase activity according to 
the brain region, as that enzymatic activity remained unaltered in striatum and 
hippocampus but increased in frontal cortex. After the first hour of acute phase of seizures 
an increase is detected in several regions (striatum, hippocampus and frontal cortex). In 
addition, catalase activity was increased in striatum, hippocampus and frontal cortex in this 
epilepsy model (Freitas et al, 2003).  
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Drugs 
Dose 
(mg/kg) 
Rats with 
lesion (%) 
Severity of 
lesion 
(%) 
Number of animals 
with lesion per group 
Pilocarpine 400 67 55.39 ± 0.52 4 
Ascorbic acid 250 00 00 0 
 500 00 00 0 
Ascorbic acid plus P400 250 33a 25.42 ± 0.25a 2 
 500 17a,b 13.46 1 
Alpha-tocopherol 200 00 00 0 
 400 00 00 0 
Alpha-tocopherol plus P400 200 00 00 0 
 400 00 00 0 
Ubiquinone 5 00 00 0 
 10 00 00 0 
Ubiquinone plus P400 5 17a 14.31 1 
 10 00 00 0 
Lipoic acid 10 00 00 0 
 20 00 00 0 
Lipoic acid plus P400 10 17a 12.96 ± 0.22a 1 
 20 00 00 0 
Pilocarpine was administered in a single dose (400 mg/kg, P400, n=6), ascorbic acid groups with 
ascorbic acid (250 or 500 mg/kg), alpha-tocopherol (200 or 400 mg/kg, n=6), ubiquinone (5 or 10 
mg/kg, n=6) and lipoic acid group with lipoic acid (10 or 20 mg/kg; n=6). The ascorbic plus P400 
groups were treated with ascorbic acid (250 or 500 mg/kg, n=6) and 30 min before P400. The alpha-
tocopherol plus P400 group was treated with alpha-tocopherol (200 or 400 mg/kg) and 30 min before 
P400. The ubiquinone plus P400 group was treated with ubiquinone (5 or 10 mg/kg) and 30 min before 
P400. The lipoic acid plus P400 group was treated with lipoic acid (10 or 20 mg/kg) and 30 min before 
P400. Severity of lesion was expressed as mean ± S.E.M. of scores of damage based on a scale from zero 
(none) to 100 (total) percent of structural involvement. Brain damage was defined as present if there 
was at least 50% straital involvement. Results for % rats with brain lesion and % severity of lesion are 
expressed as percentages of the number of animals inside in parenthesis. ap<0.05 compared with P400 
group (χ2 test). bp<0.05 compared with ascorbic acid 250 plus P400 group or alpha-tocopherol 200 
mg/kg plus P400 group or ubiquinone 5 mg/kg plus P400 group or lipoic acid 10 mg/kg plus P400 
group (χ2 test). 
Table 3. Histopathological alterations in striatum of rats pretreated with antioxidant 
compounds after 24 h of phase acute of pilocarpine-induced seizures. 
Lipid peroxidation in a tissue is an index of irreversible biological damage of the cell 
membrane phospholipid, which in turn leads to inhibition of most of the sulphydryl  
and some nonsulphydryl enzymes (Gilbert and Sawas, 1983). Lipid peroxidation level 
increase and reduce, whereas glutathione decrease can be induced by many chemicals (e.g. 
kainic acid and pilocarpine) and by many tissue injuries, and has been suggested as a 
possible mechanism for the neurotoxic effects of epileptic activity (Sah et al, 2002). Our 
findings demonstrated that lipid peroxidation levels increase after the first hour and during 
24 h of the acute phase of seizures induced by pilocarpine in hippocampus, striatum and 
frontal cortex.  
In normal conditions, there is a steady state balance between the production of ROS and their 
destruction by cellular antioxidant system. It is demonstrated that nitrite content in striatum 
and frontal cortex is augmented after seizures and status epilepticus in adult rats, suggesting a 
possible increase in ROS level, which can be involved in neuronal damage induced status 
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epilepticus. Other studies have shown that nitrite and nitrate levels were not elevated in 
patients with cryptogenic west syndrome (Vanhatalo and Riikonen, 2001), but it is tempting to 
speculate that the seizure activity per se did not account for the whole increment observed in 
nitrite and nitrate levels, and other mechanisms may be associated with this parameter in this 
epilepsy model, as well as neuronal degeneration observed in human beings. However, new 
studies using antioxidants drugs during status epilepticus induced by pilocarpine can indicate 
whether lipid peroxidation, nitrite and glutathione reduced (GSH) concentrations are involved 
in the pathophysiology of status epilepticus in this model.   
 
 
 
Fig. 3. Histopathological alterations in rat hippocampus pretreated with lipoic acid prior to 
pilocarpine-induced seizures. Severity of lesion was expressed as a mean ± S.E.M. of scores 
of damage based in a scale from zero (none) to 100 (total) percentage of hippocampus 
involvement. Brain damage was considered positive if there was at least 50% hippocampal 
involvement showed by Hematoxylin & Eosin staining (HE). Pictures (100 X) shown are 
from one representative experiment of n=8. [A]: Control group; [B]: Pilocarpine group; [C]: 
lipoic acid 10 group; [D]: lipoic acid 10 plus pilocarpine group; [E]: lipoic acid 20 group; [F]: 
lipoic acid 20 plus pilocarpine group. 
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Fig. 4. Histopathological alterations in rat hippocampus pretreated with ubiquinone prior to 
pilocarpine-induced seizures. Severity of lesion was expressed as a mean ± S.E.M. of scores 
of damage based in a scale from zero (none) to 100 (total) percentage of hippocampus 
involvement. Brain damage was considered positive if there was at least 50% hippocampal 
involvement showed by Hematoxylin & Eosin staining (HE). Pictures (100 X) shown are 
from one representative experiment of n=8. [A]: Control group; [B]: Pilocarpine group; [C]: 
Ubiquinone 5 group; [D]: Ubiquinone 10 group; [E]: Ubiquinone 20 group; [F]: Ubiquinone 5 
plus P400 group [G]: Ubiquinone 10 plus P400; [H]: Ubiquinone 20 plus P400. 
Although there were no selective brain regions particularly vulnerable to oxidative stress, 
there were some regional variations in the amount of oxidative damage observed. In the 
regions studied, there were nearly equal elevations in lipid oxidative, nitrite content and 
GSH markers that persisted during the acute phase of seizures.  
All living organisms can suffer oxidative damage, yet the animal brain is often said to be 
especially sensitive (Gilbert and Sawas, 1983; Bruce and Baudry, 1995). The experimental 
data demonstrate that pilocarpine administration and its resulting status epilepticus 
produce significant alterations in hippocampus, striatum and frontal cortex. We recorded 
alterations in superoxide dismutase activity in frontal cortex during the seizures, however, 
no alterations were observed in striatal superoxide dismutase activity of rats under the same 
conditions. It is likely that the unaltered superoxide dismutase activity in striatum might not 
be related to the mechanisms involved in installation and propagation of seizures and status 
epilepticus induced by pilocarpine, which produces several changes in parameters related to 
generation and elimination of oxygen free radicals in adult rats (Sawas and Gilbert, 1985). 
An increase in free radical formation can be accompanied by an immediate compensatory 
increase of free radical scavenging enzymatic (superoxide dismutase and catalase) activities 
and this action was observed during status epilepticus in brain regions. Nevertheless, a 
similar compensatory mechanism of scavenging was observed in catalase activity after 
status epilepticus, suggesting that the enzymatic function of different systems can be 
modified either during the acute phase of seizures or according to cerebral area 
investigated. Literature reports the involvement of catalase activity in hippocampus, 
striatum and frontal cortex after status epilepticus. An increase in catalase activity in these 
brain areas can be related to a long-term compensatory mechanism including modulation 
activity of enzymes from the ROS catabolism.  
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Moreover, the catalase activity might be one of the mechanisms capable to avoid the 
development of neurotoxic effects mediated by SE, indicating that basal-oxygen radical 
production can damage the cell and that its control is necessary (McCord, 1989; Naffah-
Mazzacoratti, 2001).  
Evidences for the role of free radicals in seizures has been found by using exogenously 
administered enzymatic and non-enzymatic antioxidants for protection against seizures 
and status epilepticus-induced neuronal damage (Kulkarni and George, 1996; Freitas et al, 
2005). A steady state level of O2- and H2O2 is always present within cells as a result of a 
normal metabolism. Superoxide dismutase and catalase are responsible for degradation of 
O2- and H2O2, respectively. The balance between antioxidants enzymes, superoxide 
dismutase and catalase can be important during seizures and status epilepticus induced 
by pilocarpine. The present data indicate that pilocarpine treatment and its resulting 
status epilepticus induce neurochemical changes such as an increase in nitrite content and 
lipid peroxidation level, a decrease in GSH content as well as an activation of brain 
antioxidant mechanisms. The anatomic distribution of alterations observed in the 
enzymatic activities (superoxide dismutase and catalase) can suggest that the frontal 
cortex can be extensively involved in the propagation of epileptic activity and further 
studies should be carried out to ascertain that the catabolism of nitrite, ROS and GSH can 
be involved in the pathogenesis of status epilepticus.  
The pilocarpine model is essential to investigate the mechanisms for initiation and 
propagation of seizures and status epilepticus. Additionally, it may be assumed that the 
increased generation of nitrite and lipid peroxidation levels after status epilepticus is not 
primary caused by an exhaustion of both the enzymatic and non-enzymatic defense systems 
measured. Adaptative mechanisms, as the induction of catalase activity, may be taken into 
consideration to counteract oxidative stress mediated by status epilepticus. However, the 
relation among brain structures, antioxidant systems, lipid peroxidation, nitrite concentration 
and status epilepticus cannot be perfectly established and deserves further investigation. 
8. Antioxidant compound effects on oxidative stress in epilepsy model  
Neurochemical alterations are observed in pilocarpine-induced seizures (Freitas et al, 2005), 
whose physiopathology is still poorly understood. However, there is data in literature 
suggesting that elevated reactive oxygen species concentrations and/or its metabolites are 
potentially neurotoxic (Freitas et al, 2004). We have demonstrated that lipoic acid reduces 
brain oxidative metabolism (Militão et al, 2010) and cannot inhibit Na+, K+-ATPase activity 
in rat hippocampus. 
Animal models are useful to better understand the pathophysiology of seizures. In this 
context, the antioxidants compound effects in pilocarpine model were recently investigated 
(Mudd et al, 2001), revealing that they might produce a decrease in nitrite levels in rat 
hippocampus (Koçak et al, 2000; Augoustides-Savvopoulou et al, 2003). Animals exposed to 
lipoic acid treatment presented no differences in physical growth and brain, suggesting that 
lipoic acid ameliorates metabolic parameters in pilocarpine model (Mesulam et al, 2002). 
By using this model, we investigated the effect of lipoic acid on spatial navigation tasks in 
the Morris water maze. Results have shown that seized rats did not present performance 
impairment neither in the acquisition phase nor on the time spent in target quadrant and in 
platform location nor in the latency to cross over the platform location in the reference 
memory task session . However, lipoic acid significantly impaired working memory 
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performance, since there was a significant effect with the 9-day interaction group and 
significant differences after days 2 and 5. 
The biological effects of free radicals are controlled in vivo by a wide range of antioxidants, 
such as alpha-tocopherol, ascorbic acid, vitamin A, and glutathione reduced (Halliwell and 
Gutteridge, 1990; Ayyildiz et al, 2006). Acid ascorbic and alpha-tocopherol have many 
functions in the brain and in the neuronal microenvironment. They work as 
neuromodulators as well as antioxidant/free radical scavengers (Koza et al, 2007; Devi et al, 
2008). It has been suggested that ascorbic acid and alpha-tocopherol have neuroprotective 
properties in some experimental models of excitotoxic neurological disorders, including 
seizure activity induced by pilocarpine (Gaby, 2007; Barros et al., 2007). 
Systemic injection of pilocarpine, a cholinergic muscarinic agonist, induces status 
epilepticus in rodents, which is associated to histopathological and neurochemical changes 
as well as oxidative stress (Turski et al, 1983; Cavalheiro et al, 1994; Freitas et al, 2005). 
Elevated free radical products were observed during the status epilepticus. Free radicals are 
highly reactive chemical compounds due to the tendency of electrons to pair, which are 
normally associated with oxidative damage (Castagne et al, 1999). 
Free radicals can be generated in the brain by several mechanisms such as inefficiency 
of the electron-carrying components of the mitochondrial transport chain, monoamines 
degradation, xanthine oxidase reaction or by metabolism of arachidonic acid. 
Nevertheless, the free radicals produced could be metabolized especially by antioxidant 
enzymes such as superoxide dismutases, catalase and glutathione peroxidase (Hussain 
et al, 1995; Meister, 1995; Frantseva et al, 2000; Ferreira et al, 2009). Then, the resulting 
free radicals are very likely to react with non-radical molecules and transform them into 
secondary free radicals, which are normally observed during the lipid peroxidation 
producing hydroperoxides (MacDonald et al, 1989). The lipid peroxidation and nitrite 
are increased in hippocampus rats during pilocarpine-induced seizures (Freitas, 2009; 
Militão et al, 2010). Thus, it is worthwhile assessing the role of antioxidant compounds 
in the prevention of these neurochemical alterations on oxidative stress during seizures. 
The excitotoxicity has been shown to be related to over-production of free radicals in 
hippocampus of adult rats. The excessive release of excitatory amino acids such as 
glutamate may kill neurons via excessive activation of their receptors facilitating the 
installation and/or propagation of seizures (MacDonald et al., 1989; Cavalheiro et al., 
1994; Meldrum, 1994). 
Depending on neuronal maturity, the glutamate may induce either apoptotic or necrotic 
types of death (Ferrer et al, 1995) by impairing the Ca2+ homeostasis and inducting the 
oxidative stress (Leite et al, 1990; Murphy and Baraban, 1990). Based on this fact, it is 
important to evaluate the role of ubiquinone on oxidative stress in rat hippocampus 
during seizures since ubiquinone is a powerful antioxidant that prevents oxidative 
damage caused by free radicals, including oxidation of lipids within the mitochondrial 
membrane (Geromel et al., 2002). 
Several antioxidant compounds, such as acid ascorbic (Xavier et al, 2007), lipoic acid 
(Freitas, 2009) and alpha-tocopherol (Barros et al, 2007) can protect the brain against 
oxidative stress in rat hippocampus caused by pilocarpine-induced seizures. Studies have 
suggested that ubiquinone (UQ) serves as an antioxidant by activating and increasing 
expression of mitochondrial uncoupling proteins which have antiapoptotic and antioxidant 
properties (Shults and Haas, 2005; Chaturvedi and Beal, 2008). Ubiquinol, a reduced form of 
ubiquinone, decreases lipid peroxidation directly by acting as a chain-breaking antioxidant 
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and indirectly by recycling alpha-tocopherol. Thus, it is important to investigate the 
neuroprotective effect of ubiquinone against hippocampal damage caused by oxidative 
stress observed during seizures.  
In addition to preventing lipid peroxidation, UQ, as an effective antioxidant, also reacts with 
ROS (James et al., 2004). This study implies that ubiquinone may alter the oxidative stress in 
rat hippocampus caused by the seizures. To further attest this hypothesis, this study was 
aimed at evaluating the effects of ubiquinone on superoxide dismutase, catalase and 
glutathione peroxidase activities as well as in hydroperoxide concentration in the rat 
hippocampus during acute phase of seizures induced by pilocarpine. 
The pilocarpine model could prove to be useful to delineate and understand the 
development of behavioral and neurochemical changes associated with temporal lobe 
epilepsy. Pilocarpine status may provide a model for studying the basic mechanisms 
responsible for refractory status epilepticus, amino acids and oxidative stress in humans and 
evaluating new drugs. The pilocarpine model may prove useful in the study of status 
epilepticus for number of reasons. First, these seizures accurately model human generalized 
epilepsy as it is seen from the anticonvulsant profile drugs. Secondly, the serve and 
refractory nature of this model indicates that it should be valuable in the development of 
new anticonvulsant agents. Finally, the prolonged and uniform degree of status epilepticus 
is useful for metabolic, neurochemical and neuroanatomical studies of the sequelae of 
prolonged seizure activity. 
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